CENTRE ANTOINE LACASSAGNE
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- -
- Established
- 1961-01-01
- Employees
- -
- Market Cap
- -
Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma
Phase 2
Completed
- Conditions
- Lymphoma
- Interventions
- Biological: rituximabRadiation: yttrium Y 90 ibritumomab tiuxetan
- First Posted Date
- 2008-06-04
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 30
- Registration Number
- NCT00690560
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
© Copyright 2025. All Rights Reserved by MedPath